Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11690825
20-HETE receptor (GPR75) antagonists and methods of use
granted -
US 11690851
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11690919
Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells
granted -
US 11690850
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11684626
Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
granted -
US 11685710
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
granted -
US 11684657
HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
granted -
US 11680067
Small molecules for the treatment of primary cancer and cancer metastasis
granted -
US 11679075
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
granted -
US 11672789
Radiation mitigator and method of use thereof
granted -
US 11673966
Monoclonal and humanized antibodies to a cancer glycopeptide
granted -
US 11673867
Sulfonamide derivative or pharmaceutically acceptable acid-addition salt
granted -
US 11667612
Compositions and methods for delivering pharmaceutical agents
granted -
US 11666634
Methods and compositions for management of gastrointestinal disorders
granted -
US 11660352
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
granted -
US 11661411
Quinoxaline compounds and uses thereof
granted -
US 11660325
Compositions and methods of targeting cancer stem cells
granted -
US 11655307
Anti-doublecortin-like kinase 1 antibodies and methods of use
granted -
US 11648209
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11648297
Bioresponsive particles
granted -
US 11648272
Human kynureninase enzymes and uses thereof
granted -
US 11648210
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11648307
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 11643438
Antimicrobial peptides and methods of use
granted